That's cute... but don't let this distract you from the fact that $KPAY has entered into a joint venture agreement with NASDAQ company Orgenesis. $KPAY will retain 100% ownership and receive 15% royalties on all future net sales! $KPAY going PARABOLIC!!
The JV shall be carried out through a company to be established by the Parties (“JV Entity”). Initially, after formation, the JV Entity shall be 100% owned by KinerjaPay.
6.5. In consideration of the rights and the KinerjaPay License to be granted to the JV Entity during the Term under the KinerjaPay License Agreement, KinerjaPay shall receive royalty in an amount of fifteen percent (15%) of the net sales generated by the JV Entity and/or its sublicensees (as applicable) with respect to the KinerjaPay Products, as to be more fully stipulated and set forth under the KinerjaPay License Agreement.
do you understand what a newly former Joint Venture is?
and do you understand that the newly former Joint Venture that has been allegedly agreed upon by KPAY and Orgenesis has ZERO revenues and will not have revenues for years to come as clinical trials need to occur first and, importantly, be successful?
Quote: Are you saying Orgenesis has no revenues now?